Emma Hall, PhD, on Bladder Cancer: Results From the BC2001 Trial

2017 Genitourinary Cancers Symposium
Tweet this page

Emma Hall, PhD, of the Institute of Cancer Research, London, discusses long-term outcomes with chemoradiotherapy vs radiotherapy alone, and standard vs reduced high-dose volume radiotherapy in muscle-invasive bladder cancer. (Abstract 280)

Advertisement

Advertisement



Advertisement